{"text": "Our results indicated that SJZ enhanced the anti-lung cancer effects of gefitinib via the key targets ABCG2, ABCC1, ABAT, GSR, CYP1A2, ALOX5, CYP3A4, PLA2G1B and PLA2G2A and the key metabolites 2-oxoglutarate, taurocholic acid, oxidized glutathione and linoleic acid. This work illustrated the modulatory properties of SJZ, which enhanced the anticancer effects of gefitinib, using metabolomics and network pharmacology analyses, and provided insights into underlying the mechanism the active ingredients of SJZfor the treatment of lung cancer in combination with gefitinib.", "denotations": [{"id": "T1", "obj": "gene", "span": {"begin": 27, "end": 30}}, {"id": "T2", "obj": "disease", "span": {"begin": 44, "end": 60}}, {"id": "T3", "obj": "gene", "span": {"begin": 102, "end": 107}}, {"id": "T4", "obj": "gene", "span": {"begin": 109, "end": 114}}, {"id": "T5", "obj": "gene", "span": {"begin": 116, "end": 120}}, {"id": "T6", "obj": "gene", "span": {"begin": 122, "end": 125}}, {"id": "T7", "obj": "gene", "span": {"begin": 127, "end": 133}}, {"id": "T8", "obj": "gene", "span": {"begin": 135, "end": 140}}, {"id": "T9", "obj": "gene", "span": {"begin": 142, "end": 148}}, {"id": "T10", "obj": "gene", "span": {"begin": 150, "end": 157}}, {"id": "T11", "obj": "gene", "span": {"begin": 162, "end": 169}}, {"id": "T12", "obj": "disease", "span": {"begin": 343, "end": 353}}, {"id": "T13", "obj": "disease", "span": {"begin": 532, "end": 543}}]}
